Article Name Europe
Led by new investor Innovation Industries, with matching contributions from existing investors, Partners in Equity and Invest-NL, the $85M round also drew support from EQT Life Sciences and Health Innovations, demonstrating strong confidence in ViCentra's next phase of growth
03rd September, 2025
By providing standardised tools and a collaborative platform, the Alliance supports physicians in advancing patient care across the region
03rd September, 2025
Through the Sectra Amplifier Service, UMG Göttingen will be able to integrate third-party AI applications into clinical workflows
02nd September, 2025
Backed by VANTAGE trial data unveiled at ESC Congress 2025 and published in JACC: Cardiovascular Interventions, Navitor now covers all surgical risk categories—while new ESC/EACTS guidelines also strengthen support for MitraClip™ and TriClip™ in mitral and tricuspid valve disease management.
01st September, 2025
The Board of Directors has also elected Antti Vasara as its new Vice Chairman and a member of the Board's Audit Committee
28th August, 2025
This is intended to ensure high-quality patient care as well as efficient medical operations
26th August, 2025
Covering both mosquito-borne diseases and emerging respiratory pathogens, Anbio continues to advance point-of-care diagnostics for timely outbreak detection worldwide
11th August, 2025
CE Certification positions SurgiBox for global expansion and robust sales acceleration
11th August, 2025
With the formation of Demetra Spine and recent acquisitions in the US and Europe, Demetra accelerates its mission to revolutionise spinal surgery through infection-reducing, single-use technologies designed for minimally invasive, value-based care.
04th August, 2025
First in the industry to achieve dual certification for both reagents and analysers within its Atellica portfolio
30th July, 2025
New minimally invasive diagnostic aids in ruling out Alzheimer’s disease early, expanding access to timely and accurate neurological assessments across Europe.
24th July, 2025
Breakthrough Minimally Invasive Solution Enhances Precision in Targeted Therapy Procedures, Supporting Improved Outcomes in Prostate Cancer Treatment
24th July, 2025
Danish multicenter study confirms clinical utility of genomic test in identifying low-risk stage I–II melanoma patients, advancing precision in surgical decision-making
22nd July, 2025
Approval now includes children as young as two, pregnant individuals, and people with type 2 diabetes across Europe
22nd July, 2025
Pivotal trial launches to evaluate XVIVO’s portable perfusion device designed to optimize heart preservation and transplantation outcomes across the U.S.
21st July, 2025
Landmark trial to evaluate world’s first autonomous, electronic artificial urinary sphincter for stress urinary incontinence in men
18th July, 2025
Pioneering Study Aims to Validate Convenient, Early Detection Method for Type 1 Diabetes Outside Clinical Settings
18th July, 2025
Strategic Move Marks Safe Life’s Entry into the Asian Market, Strengthening Its Position in Health Technology Management Across the Region
16th July, 2025
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer